Next Financial Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
Next Financial Group's NEO Position: Q4 2021 in Review
Next Financial Group reduced its NeoGenomics (NEO) stake by 30% in Q4 2021, selling an estimated $145K and leaving 8,798 shares worth $301K. The position accounts for 0.02% of the portfolio, ranked #731.
Next Financial Group first reported a position in NEO in Q1 2016 and has held it in 15 quarters since. The position peaked at $624K in Q1 2021. 309 funds tracked by Wall St. Rank hold NEO as of Q4 2021.
- Next Financial Group held 8,798 shares of NeoGenomics worth $301K as of Q4 2021.
- Next Financial Group sold 3,699 NeoGenomics shares in Q4 2021, an estimated $145K.
- NeoGenomics made up 0.02% of Next Financial Group's portfolio in Q4 2021, its #731 holding.
- Next Financial Group first reported a position in NeoGenomics in Q1 2016 and has held it in 15 quarters since.
- Next Financial Group's NeoGenomics position peaked at $624K in Q1 2021.
- 309 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.
Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.